Latest News

News Brief - PrEP

by Aaron Shepard

News Brief PrEP

A recent study performed by Kaiser Permanente of San Francisco has definitively shown how effective of a daily regimen of Truvada can be in the prevention against HIV infection.  After monitoring 657 of its clients who were on PrEP over a two year period, Kaiser announced that none of the subjects had contracted the virus.

Read more